SPATA20: A Non-Coding RNA Molecule with A Wide Range of Functions

Target Name: SPATA20

NCBI ID: G64847

SPATA20

SPATA20: A Non-Coding RNA Molecule with A Wide Range of Functions

SPATA20 (Tisp78) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study, and recent studies have shed new light on its role in various biological processes.

SPATA20 is a small non-coding RNA molecule that is known for its ability to interact with a wide range of proteins, including transcription factors. This interaction between SPATA20 and these proteins allows it to play a critical role in the regulation of gene expression and cell biology.

One of the key features of SPATA20 is its ability to form a double-stranded RNA structure. This structure allows SPATA20 to interact with proteins in a more stable and specific way, and can also facilitate the formation of RNA-protein complexes, which are important for various cellular processes.

SPATA20 has also been shown to play a role in the regulation of cell apoptosis, which is the process by which cells die when they have reached a certain level of stress or damage. During apoptosis, SPATA20 has been shown to interact with the protein Bcl- 2, which is known for its role in preventing cell apoptosis. This interaction between SPATA20 and Bcl-2 has been shown to play a critical role in the regulation of cell life and death.

Another important function of SPATA20 is its role in the regulation of cell signaling pathways. SPATA20 has been shown to interact with the protein kinase A3, which is involved in the regulation of a wide range of cellular processes, including cell signaling, cell division, and metabolism. This interaction between SPATA20 and A3 has been shown to play a critical role in the regulation of cellular processes.

SPATA20 has also been shown to play a role in the regulation of gene expression in cancer cells. In cancer cells, SPATA20 has been shown to interact with the protein p16INK4a, which is a well-known gene that is involved in the regulation of cell growth and apoptosis. This interaction between SPATA20 and p16INK4a has been shown to play a critical role in the regulation of gene expression in cancer cells.

SPATA20 has also been shown to be a potential biomarker for various diseases, including cancer. This is because its levels are often altered in cancer cells, and its interaction with other proteins has been shown to play a critical role in the regulation of cellular processes that are associated with cancer.

In conclusion, SPATA20 is a non-coding RNA molecule that has a wide range of functions in the regulation of gene expression and cell biology. Its unique structure and interaction with other proteins make it an attractive target for researchers to study, and its potential as a drug target and biomarker make it a promising area of 鈥嬧?媟esearch. Further studies are needed to fully understand the role of SPATA20 in various biological processes, including its potential as a drug target and biomarker.

Protein Name: Spermatogenesis Associated 20

Functions: May play a role in fertility regulation

The "SPATA20 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPATA20 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets